WEŁNICKI, M. Why we choose fenofibrate? Fenofibrate in long-term therapy – larger packages, greater benefits for patients with atherogenic dyslipidemia. Medycyna Faktow (J EBM), v. 18, n. 2(67), p. 290-292, 30 Jun. 2025.